FDA OKs Eli Lilly COVID-19 Drug, But Supplies Will Be Limited
Eli Lilly's monoclonal antibody for COVID-19 will be available to people 65 or older, or with underlying health conditions. Supplies will be short and allocating the medicine will be a challenge.
leia mais em NPR
No comments:
Post a Comment